GLOBAL HEALTH & SOCIAL MEDICINE
Dr. Cassell is a leader on efforts to address multidrug-resistant tuberculosis (MDRTB). She and Barry Bloom, former dean of Harvard School of Public Health, co-lead an Institute of Medicine project on drug supply chain issues related to MDRTB. She actively advises numerous government agencies, NGOs, and foundations on the scale-up of MDRTB diagnosis and treatment in endemic areas around the world, including in Russia.Dr. Cassell is advising the GHSM Sentinel Project on pediatric drug-resistant tuberculosis, a global partnership that aims to develop and deploy evidence-based strategies to prevent child deaths from drug-resistant tuberculosis.
Dr. Cassell is vice president for TB Drug Development at the Infectious Disease Research Institute in Seattle, Washington, professor emeritus and former chair, Department of Microbiology, University of Alabama at Birmingham, and former vice president for scientific affairs and distinguished Lilly research scholar for infectious diseases at Eli Lilly and Company in Indianapolis, Indiana. She founded the Forum on Drug Discovery, Development and Translation, which she continues to co-chair, at the Institute of Medicine. She has a distinguished record of national service with the National Academy of Sciences, National Institutes of Health, Centers for Disease Control, and several other national and international institutions.
PLoS neglected tropical diseases, February 14, 2019
Nature genetics, January 16, 2017
International journal of mycobacteriology, November 25, 2016
Journal of microbiological methods, May 18, 2016
Genome announcements, March 3, 2016
International journal of mycobacteriology, December 28, 2015
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, February 1, 2015
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, June 18, 2014
Journal of internal medicine, May 19, 2014
BMC microbiology, May 30, 2012
Division of Global Health Equity, Brigham and Women's Hospital